Membrane-Initiated Estradiol Signaling of Epithelial-Mesenchymal Transition-Associated Mechanisms Through Regulation of Tight Junctions in Human Breast Cancer Cells

Hormones and Cancer

Volumn 5, Issue 3, 2014, Pages 161-173

  Jiménez Salazar, Javier E ^a   Posadas Rodríguez, Pedro ^a   Lazzarini Lechuga, Roberto C ^a   Luna López, Armando ^b   Zentella Dehesa, Alejandro ^c,d   Gómez Quiroz, Luis E ^a   Königsberg, Mina ^a   Domínguez Gómez, Guadalupe ^a,e   Damián Matsumura, Pablo ^a  

^a UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^b INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NUCLEIC ACID BINDING PROTEIN; OCCLUDIN; PROTEIN TYROSINE KINASE; PROTEIN ZO1; UNCLASSIFIED DRUG; ZONA OCCLUDENS 1 ASSOCIATED NUCLEIC ACID PROTEIN; CADHERIN; CSK TYROSINE-PROTEIN KINASE; TJP1 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; COMPLEX FORMATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ESTROGEN ACTIVITY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TUMOR GROWTH; ACTIVE TRANSPORT; BREAST TUMOR; CELL MOTION; DRUG EFFECTS; FEMALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; ESTRADIOL; FEMALE; HUMANS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TIGHT JUNCTIONS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84900323223     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-014-0180-3     Document Type: Article

References (47)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 1: 43-66.
2. Hemminki K, Bevier M, Sundquist J, Hemminki A (2013) Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries. Int J Cancer 4: 944-950.
3. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 6119: 580-584.
4. Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2: 117-134.
5. Balda MS, Matter K (2000) The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 19: 2024-2033.
6. Sanchez AM, Flamini MI, Baldacci C, Goglia L, Genazzani AR, Simoncini T (2010) Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol Endocrinol 11: 2114-2125.
7. Planas-Silva MD, Waltz PK (2007) Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 1-2: 11-21.
8. Zheng S, Huang J, Zhou K, Zhang C, Xiang Q, Tan Z, Wang T, Fu X (2011) 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein Ezrin. PLoS ONE 7: e22439.
9. Sudhagar S, Sathya S, Lakshmi BS (2011) Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells. Br J Cancer 7: 953-960.
10. Vallabhaneni S, Nair BC, Cortez V, Challa R, Chakravarty D, Tekmal RR, Vadlamudi RK (2011) Significance of ER-Src axis in hormonal therapy resistance. Breast Cancer Res Treat 2: 377-385.
11. van Slambrouck S, Steelant WF (2007) Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells. Biochem J 401: 689-699.
12. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Len J et al (2003) Differential regulation of cell motility and invasion by FAK. J Cell Biol 160: 753-767.
13. Takenaga Y, Takagi N, Murotomi K, Tanonaka K, Takeo S (2009) Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia. J Cereb Blood Flow Metab 6: 1099-1108.
14. Rao RK, Basuroy S, Rao VU, Karnaky KJ Jr, Gupta A (2002) Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J Pt 2: 471-481.
15. Harder JL, Whiteman EL, Pieczynski JN, Liu CJ, Margolis B (2012) Snail destabilizes cell surface Crumbs3a. Traffic 13: 1170-1185.
16. Martin TA, Mansel RE, Jiang WG (2010) Loss of occludin leads to the progression of human breast cancer. Int J Mol Med 26(5): 723-734.
17. Clavijo-Cornejo D, Enriquez-Cortina C, López-Reyes A, Domínguez-Pérez M, Nuño N, Domínguez-Meraz M, Bucio L, Souza V, Factor VM, Thorgeirsson SS, Gutiérrez-Ruiz MC, Gómez-Quiroz LE (2013) Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes. Biochimie 6: 1177-1184.
18. Revillion F, Pawlowski V, Lhotellier V, Louchez MM, Peyrat JP (2003) mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen. Anticancer Res 2B: 1455-1460.
19. Read LD, Keith D Jr, Slamon DJ, Katzenellenbogen BS (1990) Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Cancer Res 13: 3947-3951.
20. Lattrich C, Juhasz-Boess I, Ortmann O, Treeck O (2008) Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1. Oncol Rep 19: 811-817.
21. Dati C, Antoniotti S, Taverna D, Perroteau I, De Bortoli M (1990) Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 7: 1001-1006.
22. Haldosén LA, Zhao C, Dahlman-Wright K (2014) Estrogen receptor beta in breast cancer. Mol Cell Endocrinol 382: 665-672.
23. Vincent-Salomon A, Thiery JP (2003) Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 2: 101-106.
24. Park SH, Cheung LW, Wong AS, Leung PC (2008) Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol 9: 2085-2098.
25. Zhu J, Lu X, Hua KQ, Sun H, Yu YH, Feng YJ (2012) Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression. Arch Gynecol 3: 729-737.
26. Goto N, Hiyoshi H, Ito I, Tsuchiya M, Nakajima Y, Yanagisawa J (2011) Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-β signaling pathway. Cancer Sci 8: 1501-1508.
27. Platet N, Cathiard AM, Gleizes M, Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 1: 55-67.
28. Chen YJ, Li HY, Huang CH, Twu NF, Yen MS, Wang PH, Chou TY, Liu YN, Chao KC, Yang MH (2010) Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. J Pathol 3: 261-270.
29. Thompson EW, Newgreen DF, Tarin D (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 14: 5991-5995.
30. Lösel R, Wehling M (2003) Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 1: 46-56.
31. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F (2000) Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 20: 5406-5417.
32. Sabath E, Negoro H, Beaudry S, Paniagua M, Angelow S, Shah J, Grammatikakis N, Yu AS, Denker BM (2008) Galpha12 regulates protein interactions within the MDCK cell tight junction and inhibits tight-junction assembly. J Cell Sci Pt 6: 814-824.
33. Meyer TN, Hunt J, Schwesinger C, Denker BM (2003) Galpha12 regulates epithelial cell junctions through Src tyrosine kinases. Am J Physiol Cell Physiol 5: C1281-C1293.
34. Lima WR, Parreira KS, Devuyst O, Caplanusi A, N'kuli F, Marien B, van Der Smissen P, Alves PM, Verroust P, Christensen EI, Terzi F, Matter K, Balda MS, Pierreux CE, Courtoy PJ (2010) ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells. J Am Soc Nephrol 3: 478-488.
35. Jayagopal A, Yang JL, Haselton FR, Chang MS (2011) Tight junction-associated signaling pathways modulate cell proliferation in uveal melanoma. Invest Ophthalmol Vis Sci 1: 588-593.
36. Nie M, Aijaz S, Leefa Chong San IV, Balda MS, Matter K (2009) The Y-box factor ZONAB/DbpA associates with GEF-H1/Lfc and mediates Rho-stimulated transcription. EMBO Rep 10: 1125-31.
37. Balda MS, Garrett MD, Matter K (2003) The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 3: 423-432.
38. Ye L, Martin TA, Parr C, Harrison GM, Mansel RE, Jiang WG (2003) Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J Cell Physiol 2: 362-369.
39. Lattrich C, Juhasz-Boess I, Ortmann O, Treeck O (2008) Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1. Oncol Rep 3: 811-817.
40. Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K (2007) Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res 67: 3955-3962.
41. Chen J, Xiao L, Rao JN, Zou T, Liu L, Bellavance E, Gorospe M, Wang JY (2008) JunD represses transcription and translation of the tight junction protein zona occludens-1 modulating intestinal epithelial barrier function. Mol Biol Cell 9: 3701-3712.
42. Sade H, Holloway K, Romero IA, Male D (2009) Transcriptional control of occludin expression in vascular endothelia: regulation by Sp3 and YY1. Biochim Biophys Acta 3: 175-184.
43. Braniste V, Leveque M, Buisson-Brenac C, Bueno L, Fioramonti J, Houdeau E (2009) Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells. J Physiol Pt 13: 3317-3328.
44. Martin-Belmonte F, Perez-Moreno M (2011) Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 1: 23-38.
45. Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R, Kang K, Hadsell DL, Behrens J, Lee AV (2003) Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. Cancer Res 17: 5203-5208.
46. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 3: 631-644.
47. Zhang X, Liu G, Kang Y, Dong Z, Qian Q, Ma X (2013) N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines. PLoS One 3: e57692.